ReviewExperimental hematology & oncology2024

CRISPR/Cas9 technology for advancements in cancer immunotherapy: from uncovering regulatory mechanisms to therapeutic applications.

Xiaohang Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.